2026 ACCP/UCSF Digital Health Webinar - On Demand
-
You must log in to register
- User - Free!
- Member - Free!
2026 ACCP/UCSF Digital Health Webinar
Live Session: Wednesday, April 29nd, 2026, from 1:00 to 2:30 PM ET
On Demand: April 29th, 2026 to April 29th, 2029
Why is this webinar important to your practice?
Learners who complete this activity will have strengthened knowledge of emerging digital health technologies and their application in clinical care and research. This activity reviews the convergence of extended reality (XR), artificial intelligence (AI), biosensing and digital twin technologies to enable more objective assessment, personalized interventions and improved patient outcomes. Content covers digital therapeutics, including regulatory pathways and reimbursement considerations, with emphasis on AI-driven, adaptive models and key challenges such as data variability, subjectivity of health outcomes and algorithmic fairness. This activity is designed to increase knowledge of digital health technologies and their potential to enhance clinical decision-making, patient monitoring and precision medicine approaches.
Target Audience:
Interprofessional team of Physicians, Pharmacists, PhDs and other health care professionals interested in the application of digital health technologies in patient care.
Learning Objectives
After completing this activity, the learner will be able to:
- Describe the key components of digital health technologies and their roles in clinical care;
- Explain the classification, regulatory pathways and reimbursement considerations for digital therapeutics;
- Identify opportunities and considerations for integrating digital health technologies into clinical practice, including workflow, safety, equity and patient monitoring.
Walter Greenleaf
Research & Innovations Director
Stanford University
Walter Greenleaf, Ph.D. is a neuroscientist and a medical technology developer working at Stanford University. Walter is considered a leading authority in the fields of digital medicine, wearable sensors, and medical virtual reality technology.
He is an advisor to Stanford University’s Virtual Human Interaction Lab (VHIL), to the Stanford Wearable Electronics (eWear) Program, the Stanford VR & Immersive Technology (VR-IT) Clinic, as well as the Stanford Medical Mixed Reality Center.
In addition to his research and development work at Stanford, Walter serves on the Science Advisory Board for healthcare product companies such as Abbott Labs, Penumbra, and Interaxon. Walter was the founding Chief Science Officer for Pear Therapeutics, a pioneering company in SaMD. He currently advises several venture investment firms and healthcare networks about digital health assessment and therapeutic systems.
Peter Washington
Assistant Professor
University of California, San Francisco
Dr. Peter Washington, PI of the UCSF TECH Lab (techlab.ucsf.edu), is an Assistant Professor in the Division of Clinical Informatics and Digital Transformation (DoC-IT) in the Department of Medicine at the University of California, San Francisco (UCSF). Dr. Washington's research, funded by the NIH, NSF, Weill Neurohub, and foundations, focuses on developing digital diagnostics and digital therapeutics for a wide range of health conditions and addressing fundamental human-centered AI challenges on the way towards creating these digital health innovations. He holds a PhD in Bioengineering from Stanford, MS in Computer Science from Rice, and BA in Computer Science from Rice.